Young adults and children suffering with leukemia and lymphoma now have hope as a new CAR-T Therapy Tisagenlecleucel, developed and manufactured by Novartis, has been recommended by an oncology advisory panel of The US Food and Drug Administration (FDA). Many experts believe CAR-T Therapy presents a paradigm shift in how we approach and treat cancer.
“I’m a zombie until I drink my coffee,” so say many coffee addicts who claim to not feel “alive” until they’ve had a coffee to start their day. A recent study in Annals of Internal Medicine found that drinking two to four cups of coffee reduces the likelihood of circulatory disease and cerebrovascular disease mortality.
Wednesday, 28 June 2017 by Rose-Marie Brandwein
The National Cancer Institute defines BRCA1 and BRCA2 as “human genes that produce tumor suppressor proteins. These proteins help repair damaged DNA and, therefore, play a role in ensuring the stability of the cell’s genetic material. When either of these genes mutates, or is altered, such that its protein product either is not made or does not function correctly, DNA damage may not be repaired